DNA
Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biotechnology · US
$10.07
−1.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.61x
- Price / sales
- 6.06x
- Price / cash flow
- -3.98x
Enterprise value
- Enterprise value
- $780.1M
- EV / sales
- 6.97x
- EV / EBITDA
- -3.22x
- EV / EBIT
- -2.68x
- Market cap
- $678.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026